B. Pötzsch

2.0k total citations
28 papers, 1.5k citations indexed

About

B. Pötzsch is a scholar working on Surgery, Internal Medicine and Hematology. According to data from OpenAlex, B. Pötzsch has authored 28 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 10 papers in Internal Medicine and 10 papers in Hematology. Recurrent topics in B. Pötzsch's work include Venous Thromboembolism Diagnosis and Management (10 papers), Heparin-Induced Thrombocytopenia and Thrombosis (8 papers) and Platelet Disorders and Treatments (6 papers). B. Pötzsch is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (10 papers), Heparin-Induced Thrombocytopenia and Thrombosis (8 papers) and Platelet Disorders and Treatments (6 papers). B. Pötzsch collaborates with scholars based in Germany, United States and Austria. B. Pötzsch's co-authors include Andreas Greinacher, C Mueller-Eckhardt, Jean Amiral, Angelika Eichner, Petra Eichler, B. Kemkes‐Matthes, H. Völpel, V. Hach-Wunderle, Uwe Janssens and Jens Müller and has published in prestigious journals such as Circulation, The Journal of Immunology and Neurology.

In The Last Decade

B. Pötzsch

28 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Pötzsch Germany 15 995 635 553 501 291 28 1.5k
Krystin Krauel Germany 18 777 0.8× 380 0.6× 831 1.5× 332 0.7× 137 0.5× 35 1.5k
Jacob Luboshitz Israel 15 293 0.3× 88 0.1× 682 1.2× 118 0.2× 64 0.2× 34 1.3k
Ilia Tamarin Israel 20 183 0.2× 145 0.2× 844 1.5× 25 0.0× 279 1.0× 51 1.3k
Patrick Yeramian United States 11 906 0.9× 111 0.2× 86 0.2× 22 0.0× 57 0.2× 16 1.3k
H F Kotzé South Africa 15 209 0.2× 79 0.1× 418 0.8× 17 0.0× 125 0.4× 39 779
Alina D. Peshkova United States 17 103 0.1× 253 0.4× 468 0.8× 16 0.0× 127 0.4× 40 983
Cristina Puy United States 21 74 0.1× 156 0.2× 812 1.5× 13 0.0× 195 0.7× 51 1.3k
Lena Hell Austria 17 89 0.1× 156 0.2× 133 0.2× 17 0.0× 133 0.5× 29 899
Robbie K. Montgomery United States 17 138 0.1× 24 0.0× 325 0.6× 188 0.4× 36 0.1× 33 1.0k
Netanel A. Horowitz Israel 17 60 0.1× 100 0.2× 215 0.4× 26 0.1× 46 0.2× 77 1.0k

Countries citing papers authored by B. Pötzsch

Since Specialization
Citations

This map shows the geographic impact of B. Pötzsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Pötzsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Pötzsch more than expected).

Fields of papers citing papers by B. Pötzsch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Pötzsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Pötzsch. The network helps show where B. Pötzsch may publish in the future.

Co-authorship network of co-authors of B. Pötzsch

This figure shows the co-authorship network connecting the top 25 collaborators of B. Pötzsch. A scholar is included among the top collaborators of B. Pötzsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Pötzsch. B. Pötzsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pötzsch, B.. (2013). Antikoagulation. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 108(4). 325–336. 3 indexed citations
2.
Müller, Jens, Matthias G. Friedrich, Tobias Becher, et al.. (2012). Monitoring of plasma levels of activated protein C using a clinically applicable oligonucleotide‐based enzyme capture assay. Journal of Thrombosis and Haemostasis. 10(3). 390–398. 39 indexed citations
4.
Rohrbach, Falk, B. Pötzsch, Jens Müller, & Günter Mayer. (2011). Aptamer-based modulation of blood coagulation. Hämostaseologie. 31(4). 258–263. 34 indexed citations
5.
Ivaškevičius, Vytautas & B. Pötzsch. (2011). Haemostasis management of massive bleeding. Hämostaseologie. 31(1). 15–20. 11 indexed citations
6.
Müller, Jens, Daniel F. Freitag, Günter Mayer, & B. Pötzsch. (2008). Anticoagulant characteristics of HD1‐22, a bivalent aptamer that specifically inhibits thrombin and prothrombinase. Journal of Thrombosis and Haemostasis. 6(12). 2105–2112. 100 indexed citations
7.
Seidel, H., B. Pötzsch, Matthias Watzka, & Johannes Oldenburg. (2008). Neue Einsichten in die orale Antikoagulationstherapie mit Cumarinen. Hämostaseologie. 28(01/02). 44–50. 5 indexed citations
8.
Greinacher, Andreas, et al.. (2006). Empfehlungen zur Thrombozytentransfusion. DMW - Deutsche Medizinische Wochenschrift. 131(47). 2675–2679. 14 indexed citations
9.
Neuhaus, T., et al.. (2002). [Recurrent spontaneous hemorrhage in a patient with light chain immunocytoma].. PubMed. 91(4). 112–8. 1 indexed citations
10.
Stolz, Erwin, et al.. (2000). Screening for thrombophilic risk factors among 25 German patients with cerebral venous thrombosis. Acta Neurologica Scandinavica. 102(1). 31–36. 34 indexed citations
11.
Eichler, Petra, U. Budde, Sylvia Haas, et al.. (1999). First Workshop for Detection of Heparin-induced Antibodies: Validation of the Heparin-induced Platelet-activation Test (HIPA) in Comparison with a PF4/Heparin ELISA. Thrombosis and Haemostasis. 81(4). 625–629. 127 indexed citations
12.
Wagner, Dorothea, G. Kleber, Andreas K. Lindner, B. Pötzsch, & Wolfgang E. Fleig. (1998). 19jähriger Patient mit generalisiertem Krampfanfall und rezidivierenden Thrombosen unter Heparintherapie. Der Internist. 39(7). 766–769. 5 indexed citations
13.
Grimminger, Friedrich, Frank Rose, Ulf Sibelius, et al.. (1997). Human endothelial cell activation and mediator release in response to the bacterial exotoxins Escherichia coli hemolysin and staphylococcal alpha-toxin. The Journal of Immunology. 159(4). 1909–1916. 73 indexed citations
14.
Pötzsch, B., N. Bleese, Andreas Greinacher, et al.. (1997). Rekombinantes Hirudin als Antikoagulans für den kardiopulmonalen Bypass in der Herzchirurgie: Klinische Erfahrungen. Zeitschrift für Herz- Thorax- und Gefäßchirurgie. 11(2). 79–87. 10 indexed citations
15.
Pötzsch, B., et al.. (1995). Acquired protein C dysfunction but not decreased activity of thrombomodulin is a possible marker of thrombophilia in patients with lupus anticoagulant.. PubMed. 125(1). 56–65. 24 indexed citations
16.
Greinacher, Andreas, et al.. (1994). Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen.. PubMed. 71(2). 247–51. 374 indexed citations
17.
Krug, Bárbara, et al.. (1994). Heparin-associated thrombosis despite normal platelet counts.. PubMed. 344(8920). 469–70. 53 indexed citations
18.
Greinacher, Andreas, et al.. (1993). Evidence that DDAVP transiently improves hemostasis in Bernard-Soulier syndrome independent of von Willebrand-Factor. Annals of Hematology. 67(3). 149–150. 23 indexed citations
19.
Pötzsch, B., et al.. (1990). Identification of endothelial and mesothelial cells in human omental tissue and in omentum-derived cultured cells by specific cell markers.. PubMed. 63(6). 841–52. 46 indexed citations
20.
Pötzsch, B., et al.. (1987). Microvascular endothelial cells from human omental tissue: Modified method for long-term cultivation and new aspects of characterization. Microvascular Research. 34(2). 239–249. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026